Celanese (CE)
(Delayed Data from NYSE)
$71.37 USD
+2.60 (3.78%)
Updated Feb 4, 2025 04:00 PM ET
Pre-Market: $71.30 -0.07 (-0.10%) 9:08 AM ET
5-Strong Sell of 5 5
B Value F Growth B Momentum D VGM
Price, Consensus and EPS Surprise
CE 71.37 +2.60(3.78%)
Will CE be a Portfolio Killer in February?
Zacks Investment Research is releasing its prediction for CE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CE
Celanese and Cloverdale Paint Partner for Sustainable Paint Solutions
Why Is Celanese (CE) Down 20.3% Since Last Earnings Report?
CE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Celanese Partners Henkel for Adhesives Made of Captured CO2 Emissions
Should You Invest in the First Trust Materials AlphaDEX ETF (FXZ)?
Celanese's Q3 Earnings and Revenues Miss Estimates, Decline Y/Y
Other News for CE
Demystifying Celanese: Insights From 10 Analyst Reviews
Celanese price target lowered to $75 from $88 at Barclays
Celanese price target lowered by $13 at Barclays, here's why
Celanese (CE) Receives a Hold from Barclays
Oakmark U.S. Large Value Strategy Q4 2024 Commentary